Kolexia
Melaine Boscagli Annick Médecine interne
Melaine Boscagli Annick
Médecine interne
Centre Hospitalier de Royan
Royan, France
33 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Maladie de Hodgkin Lymphome malin non hodgkinien Anémie Sepsie Néphrite interstitielle Infections opportunistes liées au SIDA Myélome multiple Histiocytose

Collaborateurs

Voir plus
Gastaud Lauris
Gastaud Lauris
Centre Antoine Lacassagne, Nice, France
Thyss Antoine
Thyss Antoine
Centre Antoine Lacassagne, Nice, France
Re Daniel
Re Daniel
Centre Hospitalier de Antibes, Antibes, France
Peyrade Frederic
Peyrade Frederic
Centre Antoine Lacassagne, Nice, France

Industries

Voir plus
A+A
26 collaboration(s)
Dernière en 2020
B3TSI
16 collaboration(s)
Dernière en 2020
Abbvie
1 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin.
Frontiers in oncology   28 août 2020
Large retrospective study of lenalidome-dexamethasone (Rd) in patients older than 80 with multiple myeloma (MM): Is less more?
2018 ASCO Annual Meeting I   01 juin 2018
Autologous stem cell transplantation (ASCT) is safe and effective for the treatment of non-hodgkin lymphoma (NHL) in an elderly population of patients over 65 years old: A single center experience
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
Un syndrome cave supérieur bien particulier
3es Journées Francophones de Médecine Nucléaire   01 mai 2017
Short-course daptomycin lock and systemic therapy for catheter-related bloodstream infections: a retrospective cohort study in cancer patients with surgically implanted devices.
Journal of chemotherapy (Florence, Italy)   25 janvier 2017
Autoimmune hemolytic anemia after nivolumab treatment in Hodgkin lymphoma responsive to immunosuppressive treatment. A case report.
Hematological oncology   19 août 2016
Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma.
Experimental hematology & oncology   04 juillet 2015
High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma.
Leukemia & lymphoma   20 février 2015
Visceral leishmaniasis due to Leishmania infantum with renal involvement in HIV-infected patients.
BMC infectious diseases   30 octobre 2014
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}